*Long_covid* ❝Les poumons sont l’organe cible de l’infection par le SRAS-CoV-2, et facteur…

/893891

  • Post-COVID lungs worse than the worst smokers’ lungs, surgeon says - CBS News
    https://www.cbsnews.com/news/covid-lungs-scarring-smokers-lungs

    Bankhead-Kendall, an assistant professor of surgery with Texas Tech University, in Lubbock, has treated thousands of patients since the pandemic began in March.

    She says patients who’ve had #COVID-19 symptoms show a severe chest X-ray every time, and those who were asymptomatic show a severe chest X-ray 70% to 80% of the time.

    • Quelqu’un sait si le scan ou la radio des poumons sont utilisés en France, en détection (p.ex. asymptomatiques) et en diagnostic (confirmation et/ou évaluation des dégâts) ?

      Sur les quelques cas dont j’ai entendu parler dans mon entourage, il n’a jamais été question de radio ou de scan ; il paraît que l’IHU de Marseille - et sans doute d’autres hostos - scannent systématiquement leurs clients ; j’ai pas d’info sur les médecins de ville.

      SPF ne publie pas de compteur du nombre de radios/scans et le taux de positifs, si ? :-p

      –---

      https://www.assemblee-nationale.fr/dyn/15/comptes-rendus/covid19/l15covid191920028_compte-rendu

      Raoult en commission parlementaire - 24/06/2020

      Presque tous les patients hospitalisés et beaucoup de patients en hôpital de jour ont bénéficié de scanners à faible dose, qui auraient dû remplacer depuis très longtemps les téléthorax – la France souffre d’un manque catastrophique d’équipements radiologiques par rapport aux autres pays de l’OCDE. Parmi les 2 400 examens pratiqués grâce à la mobilisation jour et nuit des radiologues, certains ont révélé des lésions pulmonaires chez des patients asymptomatiques. Cela nous a amenés à vérifier leur saturation en oxygène. Ceux qui nous semblaient exposés à un danger ont été hospitalisés et ceux qui sont rentrés chez eux ont été suivis.

  • Covid-19 : fatigue, faiblesse musculaire, atteintes pulmonaires… trois patients sur quatre présenteraient des symptômes durables
    https://www.lemonde.fr/planete/article/2021/01/09/covid-19-fatigue-faiblesse-musculaire-atteintes-renales-ou-pulmonaires-trois

    « The Lancet » a publié samedi une étude portant sur une cohorte de plus de 1 700 patients chinois hospitalisés au printemps 2020, qui montre que 76 % d’entre eux souffraient encore, six mois plus tard, d’au moins un symptôme.

    • 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study - The Lancet
      https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32656-8/abstract

      Summary
      Background
      The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.

      Methods
      We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded. All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests. A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5–6, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography. Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.

      Findings
      In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0–65·0) years and 897 (52%) were men. The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186·0 (175·0–199·0) days. Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms. Anxiety or depression was reported among 23% (367 of 1617) of patients. The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5–6. The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5–6, and median CT scores were 3·0 (IQR 2·0–5·0) for severity scale 3, 4·0 (3·0–5·0) for scale 4, and 5·0 (4·0–6·0) for scale 5–6. After multivariable adjustment, patients showed an odds ratio (OR) 1·61 (95% CI 0·80–3·25) for scale 4 versus scale 3 and 4·60 (1·85–11·48) for scale 5–6 versus scale 3 for diffusion impairment; OR 0·88 (0·66–1·17) for scale 4 versus scale 3 and OR 1·77 (1·05–2·97) for scale 5–6 versus scale 3 for anxiety or depression, and OR 0·74 (0·58–0·96) for scale 4 versus scale 3 and 2·69 (1·46–4·96) for scale 5–6 versus scale 3 for fatigue or muscle weakness. Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96·2% vs 58·5%) and median titres (19·0 vs 10·0) of the neutralising antibodies were significantly lower compared with at the acute phase. 107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1·73 m2 or more at acute phase had eGFR less than 90 mL/min per 1·73 m2 at follow-up.

      Interpretation
      At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.

      article complet accessible


      Figure 2Risk factors associated with diffusion impairment and CT score (A), and anxiety or depression and fatigue or muscle weakness (B)
      For associations of age, cigarette smoking, and education with outcome measure, the variables including age, gender, cigarette smoking, education, comorbidity, corticosteroids, antivirals, and intravenous immunoglobulin were all included in the models. For association of comorbidity with outcome, the aforementioned variables were all included together with comorbidity. For association of other factors including sex, corticosteroid, antiviral, and intravenous immunoglobulin with outcome, disease severity and the aforementioned variables were included in the model. OR (95% CI) or β (95% CI) for age indicates the risk of diffusion impairment, CT score, anxiety or depression, and fatigue or muscle weakness per 10-year age increase. OR=odds ratio.